NIAID head Dr. Anthony Fauci said preliminary data about the drug were positive, on the same day another study showed little benefit from its use.
Gilead’s Antiviral Remdesivir Had A Good Day – But It’s Still Not Clear How Effective It Is Against COVID-19
